Skip to content

Closure of oroantral communications using a biodegradable polyurethane foam; a refined procedure

Closure of oroantral communications using a biodegradable polyurethane foam; a refined procedure - The *RAPID* Study II

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32148
Enrollment
10
Registered
2008-12-04
Start date
2008-06-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oroantral communication (OAC) oroantral fistula/perforation

Interventions

All patients (n = 10) will be treated in the same manner. The size of the oroantral communication will be examined and a polyurethane foam is selected that matches its size. Secondly, a suture is at

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Fresh oroantral communication (existing less than 24 hours)

Exclusion criteria

Exclusion criteria: Oroantral communication existing for more than 24 hours. Patients who require endocarditisprophylaxis or antobiotic prophylaxis for other indications. A history of acute or chronic sinusitis. Immune compromised patients.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the technical success, defined as the successful application of the polyurethane foam, without reoccurence of a perforation secondary to loss of the foam or inadequate fitting. The oral mucosal overgrowth will be examined to evaluate these endpoints. Safety parameters: the safety outcome of the study will be described in terms of the incidence of procedure or device related adverse events occuring up to and including 8 weeks after application in the oroantral perforation.

Secondary

MeasureTime frame
patient friendliness and device appreciation (physician)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)